Light & Wonder, Inc. ("Light & Wonder," "L&W," "we" or the "Company") is providing an update on today's ruling from the Nevada Court regarding the ongoing litigation with Aristocrat. The Nevada Court ...
Merck leads U.S. pharma in 2025, but faces Keytruda patent loss by 2028. Click for my look at MRK stock ahead of its upcoming ...
24-year-old founder and CEO Carina Hong created Axiom Math in March 2025 and has recruited a team of ten employees, most of whom are from Meta, to build a math-focused AI model. Last fall, Carina Hong ...
This is read by an automated voice. Please report any issues or inconsistencies here. American students are experiencing a math crisis marked by a decline in scores that began over a decade ago and ...
Every summer, scores of tourists take to the bustling streets of Barcelona, a city known for its breathtaking architecture. Nicolás Atanes Santos, a young Spanish mathematician, sees this as an ...
In the third century BCE, Apollonius of Perga asked how many circles one could draw that would touch three given circles at exactly one point each. It would take 1,800 years to prove the answer: eight ...
REDMOND, Wash., Sept. 24, 2025 /PRNewswire/ -- SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced the presentation of data on iza-bren (izalontamab brengitecan) and ...
The first term of my master’s degree in economics was an alarming experience. The econometrics was bewildering. The macroeconomics was even more mysterious. Everything was drenched in incomprehensible ...
Much has been written about the various attempts to create more Republican House districts through extreme gerrymandering. This column recently discussed a pending Supreme Court case that could strike ...
Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.
Jiangsu Hengrui Pharmaceuticals’ dealmaking spree rolls on, with a potential $1.1 billion transaction on a rival to AstraZeneca and Daiichi Sankyo’s blockbuster Enhertu being the latest addition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback